Dose justification for [fam-] trastuzumab deruxtecan (DS-8201a) in HER2-positive breast cancer Meeting Abstract
| Authors: | Takahashi, S.; Modi, S.; Tsurutani, J.; Krop, I. E.; Iwata, H.; Wada, R.; Yin, O.; Garimella, T.; Sugihara, M.; Zhang, L.; Lee, C.; Saito, K.; Kawasaki, Y.; Yver, A.; Tamura, K. |
| Abstract Title: | Dose justification for [fam-] trastuzumab deruxtecan (DS-8201a) in HER2-positive breast cancer |
| Meeting Title: | 17th Annual Meeting of the Japanese Society of Medical Oncology (JSMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2019 Jul 18-20 |
| Meeting Location: | Kyoto, Japan |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz339.009 |
| Language: | English |
| ACCESSION: | WOS:000491239300192 |
| DOI: | 10.1093/annonc/mdz339.009 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: O1-8-4 -- Appears on page vi84 of the abstract book -- Source: Wos |
